journal article·2026-05Open access

Detachment‐Induced FAK‐STAT3‐NNMT Inhibits CTCs Anoikis to Promote Breast Cancer Metastasis by Enhancing Fatty Acid Oxidation

Qingchao Tong, Yilei Ma, Yuzhen Gao, Lin Zhou, Luping Lou, Qiang Fang, Sining Fang, Ru Zhao, Jin Zeng, Jun Yang, Guoli Li, Xinyou Xie, Yanzhong Wang, Jun Zhang

Advanced Science· Volume 13· Issue 29

Abstract

ABSTRACT Breast cancer metastasis claims the majority of breast cancer‐related deaths. Anoikis resistance is a key prerequisite for CTCs survival and metastasis. Previous studies have demonstrated that Nicotinamide N‐methyltransferase (NNMT) plays a crucial role in cancer metastasis and apoptosis resistance. However, whether NNMT participates in breast cancer CTCs anoikis remains unexplored. In this study, the upregulation of NNMT was observed in CTCs from breast cancer patients and mouse CTCs models. NNMT in detached breast cancer cells is induced by FAK‐STAT3 axis and resists anoikis through FAO activation, promoting CTCs survival. Mechanistically, NNMT promotes the expression of CPT1A and CD36 by suppressing PP2A methylation to enhance FAO. Furthermore, NNMT‐induced FAO accelerates ROS clearance by maintaining NADP+/NADPH balance. In vivo experiments show that NNMT‐knockdown, NNMT inhibitors and FAO inhibitors can all reduce lung metastases formation, suggesting that targeting NNMT‐FAO suppresses the metastatic potential of breast cancer. Our study revealed that the upregulation of NNMT is induced by FAK‐STAT3 axis, which contributes to CTCs anoikis resistance in breast cancer by activating FAO. Targeting NNMT may provide new therapeutic targets for metastatic breast cancer.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Cancer, Lipids, and Metabolism · Sirtuins and Resveratrol in Medicine · Lipid metabolism and biosynthesis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Clinical Laboratory Sir Run Run Shaw Hospital Zhejiang University School of Medicine Hangzhou Zhejiang P. R. China

Key Laboratory of Precision Medicine in Diagnosis and Monitoring Research of Zhejiang Province Hangzhou Zhejiang P. R. China

Funding

National Natural Science Foundation of China · China Scholarship Council · Key Research and Development Program of Zhejiang Province · Natural Science Foundation of Zhejiang Province

References (68)

Show source-provided references
1. 10.3322/caac.2166010.3322/caac.21660 ↗
2. 10.1016/j.semcancer.2019.08.01210.1016/j.semcancer.2019.08.012 ↗
3. 10.1038/s41591‐020‐01195‐410.1038/s41591‐020‐01195‐4 ↗
4. 10.1016/j.cell.2023.03.00310.1016/j.cell.2023.03.003 ↗
5. 10.1007/s10555‐024‐10178‐710.1007/s10555‐024‐10178‐7 ↗
6. 10.1038/s41568‐022‐00536‐410.1038/s41568‐022‐00536‐4 ↗
7. 10.1016/j.apsb.2015.07.00510.1016/j.apsb.2015.07.005 ↗
8. 10.1186/s12964‐023‐01183‐410.1186/s12964‐023‐01183‐4 ↗
9. 10.1016/j.bbamcr.2013.06.02610.1016/j.bbamcr.2013.06.026 ↗
10. 10.1186/s13046-022-02242-310.1186/s13046-022-02242-3 ↗
11. 10.1097/HEP.000000000000093410.1097/HEP.0000000000000934 ↗
12. 10.1016/j.canlet.2018.09.03310.1016/j.canlet.2018.09.033 ↗
13. 10.1016/j.redox.2018.04.01610.1016/j.redox.2018.04.016 ↗
14. 10.1038/cddis.2016.13210.1038/cddis.2016.132 ↗
15. 10.1016/j.cmet.2017.11.00110.1016/j.cmet.2017.11.001 ↗
16. 10.3390/cells912260010.3390/cells9122600 ↗
17. 10.3892/ol.2014.228710.3892/ol.2014.2287 ↗
18. 10.1016/j.abb.2014.08.01710.1016/j.abb.2014.08.017 ↗
19. 10.1186/s13058‐019‐1150‐z10.1186/s13058‐019‐1150‐z ↗
20. 10.7150/jca.5641910.7150/jca.56419 ↗
21. 10.15252/embj.202211255910.15252/embj.2022112559 ↗
22. Nicotinamide N‑Methyltransferase Induces the Proliferation and Invasion of Squamous Cell Carcinoma Cells
23. 10.3892/or.2021.806110.3892/or.2021.8061 ↗
24. 10.1038/nchembio.120410.1038/nchembio.1204 ↗
25. 10.1016/j.canlet.2022.21588410.1016/j.canlet.2022.215884 ↗
26. 10.1371/journal.pone.008920210.1371/journal.pone.0089202 ↗
27. 10.1002/advs.20230590710.1002/advs.202305907 ↗
28. 10.1186/s12964‐016‐0157‐710.1186/s12964‐016‐0157‐7 ↗
29. 10.1007/s00432‐007‐0318‐610.1007/s00432‐007‐0318‐6 ↗
30. 10.1158/0008‐5472.CAN‐18‐384210.1158/0008‐5472.CAN‐18‐3842 ↗
31. 10.1089/ars.2021.015710.1089/ars.2021.0157 ↗
32. 10.1038/s41467‐021‐27460‐910.1038/s41467‐021‐27460‐9 ↗
33. 10.1038/s42003-023-04693-610.1038/s42003-023-04693-6 ↗
34. 10.1038/s41569‐021‐00569‐610.1038/s41569‐021‐00569‐6 ↗
35. 10.1021/bi200761410.1021/bi2007614 ↗
36. 10.3109/10409238.2016.114391310.3109/10409238.2016.1143913 ↗
37. 10.3390/cancers1421522710.3390/cancers14215227 ↗
38. 10.1038/s41416‐019‐0711‐310.1038/s41416‐019‐0711‐3 ↗
39. 10.1093/cvr/cvs18910.1093/cvr/cvs189 ↗
40. 10.1038/nature0826810.1038/nature08268 ↗
41. 10.1038/s41523‐021‐00374‐x10.1038/s41523‐021‐00374‐x ↗
42. 10.1089/ars.2019.780310.1089/ars.2019.7803 ↗
43. 10.1016/j.freeradbiomed.2013.07.03610.1016/j.freeradbiomed.2013.07.036 ↗
44. 10.3390/biom1109129510.3390/biom11091295 ↗
45. 10.1002/hep.3116510.1002/hep.31165 ↗
46. Survival Mechanisms and Influence Factors of Circulating Tumor Cells10.1155/2018/6304701 ↗
47. 10.1002/ijc.2939910.1002/ijc.29399 ↗
48. Nicotinamide N ‐methyltransferase Promotes M2 Macrophage Polarization by IL6 and MDSC Conversion by GM‐CSF in Gallbladder Carcinoma
49. 10.1016/j.intimp.2023.11044510.1016/j.intimp.2023.110445 ↗
50. 10.1016/0304‐4165(84)90075‐810.1016/0304‐4165(84)90075‐8 ↗
51. 10.1038/s41389‐018‐0064‐410.1038/s41389‐018‐0064‐4 ↗
52. 10.18632/oncotarget.996210.18632/oncotarget.9962 ↗
53. 10.7150/thno.2821910.7150/thno.28219 ↗
54. 10.1038/s41388-018-0384-z10.1038/s41388-018-0384-z ↗
55. 10.7150/thno.4402510.7150/thno.44025 ↗
56. 10.1016/j.redox.2022.10254410.1016/j.redox.2022.102544 ↗
57. 10.1038/nm.388210.1038/nm.3882 ↗
58. 10.1093/jn/113.2.21510.1093/jn/113.2.215 ↗
59. 10.3389/fcvm.2021.72181410.3389/fcvm.2021.721814 ↗
60. 10.1038/nature1319810.1038/nature13198 ↗
61. 10.1080/21655979.2022.207476810.1080/21655979.2022.2074768 ↗
62. 10.1007/s11060‐004‐6404‐610.1007/s11060‐004‐6404‐6 ↗
63. 10.1007/s13238‐017‐0451‐110.1007/s13238‐017‐0451‐1 ↗
64. 10.1038/s41392‐024‐01772‐w10.1038/s41392‐024‐01772‐w ↗
65. 10.7150/thno.2145110.7150/thno.21451 ↗
66. 10.1042/CS2006030710.1042/CS20060307 ↗
67. 10.1021/acsami.9b0965510.1021/acsami.9b09655 ↗
68. 10.1016/j.molcel.2017.11.02510.1016/j.molcel.2017.11.025 ↗